Sign In
Buy CRMD
$8.23
+0.0600 (+0.734%)
At Close: Jun 03, 2026
U.S. FDA approves CorMedix's antimicrobial drug
10:11am, Wednesday, 15'th Nov 2023
The U.S. Food and Drug Administration (FDA) on Wednesday approved CorMedix's antimicrobial drug that aims to reduce catheter-related bloodstream infections (CRBSIs) in patients with kidney disease, th
CorMedix Inc. (CRMD) Q3 2023 Earnings Call Transcript
09:55pm, Tuesday, 14'th Nov 2023
CorMedix Inc. (NASDAQ:CRMD ) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Daniel Ferry - LifeSci Advisors Joseph Todisco - CEO Matt David - EVP and CFO Phoebe Mou
CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023
08:30am, Thursday, 02'nd Nov 2023
BERKELEY HEIGHTS, N.J., Nov. 02, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention an
CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
08:30am, Tuesday, 26'th Sep 2023
BERKELEY HEIGHTS, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention a
Why Shares of CorMedix Are Slumping Thursday
12:22pm, Thursday, 29'th Jun 2023
CorMedix's lead therapy is DefenCath. The company is awaiting word from the FDA on the therapy's approval.
Why Is Cormedix (CRMD) Stock Down 23% Today?
09:30am, Thursday, 29'th Jun 2023
Cormedix (NASDAQ: CRMD ) stock is falling hard on Thursday after the company priced a public offering of its shares. That public offering has the company selling 7.5 million shares of CRMD stock at a
Cormedix Inc. To Present At The Jefferies Healthcare Conference
08:30am, Tuesday, 30'th May 2023
BERKELEY HEIGHTS, N.J., May 30, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and
CorMedix Inc. (CRMD) Q1 2023 Earnings Call Transcript
07:27pm, Monday, 15'th May 2023
CorMedix Inc. (NASDAQ:CRMD ) Q1 2023 Earnings Call May 15, 2023 4:30 PM ET Company Participants Joe Todisco - Chief Executive Officer Matt David - Executive Vice President and Chief Financial Officer
CorMedix Inc. to Participate in Two Upcoming Investor Conferences
08:30am, Wednesday, 03'rd May 2023
BERKELEY HEIGHTS, N.J., May 03, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and
7 Small-Cap Biotech Stocks with Massive Potential
06:36pm, Thursday, 27'th Apr 2023
While unproven biotechnology firms almost always carry significant risks, small-cap biotech stocks in particular typically impose jaw-dropping volatility. Along with the usual risk of clinical disappo
Here's Why CorMedix (CRMD) Looks Ripe for Bottom Fishing
11:27am, Thursday, 27'th Apr 2023
After losing some value lately, a hammer chart pattern has been formed for CorMedix (CRMD), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisi
Cormedix Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update on March 30, 2023
08:30am, Tuesday, 21'st Mar 2023
BERKELEY HEIGHTS, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention a
Cormedix Inc. Announces Presentation at Conference Showing Mortality Risk and Complications in Patients Experiencing Catheter Related Blood Stream Infections
01:30pm, Tuesday, 06'th Dec 2022 GlobeNewswire Inc.
BERKELEY HEIGHTS, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention
5 Penny Stocks To Buy According To Analysts, Targets Up To 353%
03:38pm, Friday, 11'th Nov 2022 PennyStocks
Analysts say these are penny stocks to buy. Do you agree?
The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 353% appeared first on Penny Stocks to Buy, Picks, News and Information |
5 Penny Stocks To Buy According To Analysts, Targets Up To 353%
10:38am, Friday, 11'th Nov 2022
Analysts say these are penny stocks to buy. Do you agree?
